Zhejiang Gongdong Medical Technology Co.,Ltd.
SSE:605369.SS
27.39 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,115.21 | 975.084 | 1,468.685 | 1,194.254 | 829.652 | 552.98 | 482.552 | 431.301 | 371.249 |
| Cost of Revenue
| 749.49 | 661.424 | 888.561 | 664.528 | 418.792 | 307.372 | 285.454 | 250.832 | 220.078 |
| Gross Profit
| 365.72 | 313.66 | 580.124 | 529.726 | 410.86 | 245.608 | 197.097 | 180.469 | 151.171 |
| Gross Profit Ratio
| 0.328 | 0.322 | 0.395 | 0.444 | 0.495 | 0.444 | 0.408 | 0.418 | 0.407 |
| Reseach & Development Expenses
| 50.157 | 47.815 | 72.345 | 58.291 | 36.981 | 22.335 | 18.862 | 16.792 | 14.827 |
| General & Administrative Expenses
| 24.32 | 25.645 | 40.17 | 22.297 | 12.566 | 9.424 | 10.135 | 10.404 | 27.931 |
| Selling & Marketing Expenses
| 33.652 | 43.603 | 63.364 | 57.278 | 51.327 | 46.557 | 42.16 | 36.809 | 32.604 |
| SG&A
| 57.972 | 69.248 | 103.534 | 79.574 | 63.893 | 55.981 | 52.295 | 47.213 | 60.534 |
| Other Expenses
| 63.124 | 76.877 | 65.009 | 47.361 | 33.226 | 33.558 | 2.572 | -0.692 | -0.205 |
| Operating Expenses
| 174.141 | 193.94 | 240.888 | 185.226 | 134.099 | 111.874 | 100.914 | 121.81 | 80.336 |
| Operating Income
| 191.579 | 119.721 | 371.835 | 359.723 | 263.263 | 132.401 | 95.827 | 56.912 | 70.626 |
| Operating Income Ratio
| 0.172 | 0.123 | 0.253 | 0.301 | 0.317 | 0.239 | 0.199 | 0.132 | 0.19 |
| Total Other Income Expenses Net
| -2.843 | -0.495 | -1.169 | 1.008 | -0.845 | -0.448 | 2.572 | -0.692 | -0.205 |
| Income Before Tax
| 188.735 | 119.225 | 370.666 | 360.731 | 262.417 | 131.952 | 98.399 | 56.22 | 70.42 |
| Income Before Tax Ratio
| 0.169 | 0.122 | 0.252 | 0.302 | 0.316 | 0.239 | 0.204 | 0.13 | 0.19 |
| Income Tax Expense
| 17.231 | 10.099 | 44.618 | 49.744 | 36.536 | 18.363 | 13.472 | 11.968 | 9.9 |
| Net Income
| 171.633 | 109.126 | 326.041 | 310.987 | 225.881 | 113.59 | 84.927 | 44.252 | 60.521 |
| Net Income Ratio
| 0.154 | 0.112 | 0.222 | 0.26 | 0.272 | 0.205 | 0.176 | 0.103 | 0.163 |
| EPS
| 1.09 | 0.69 | 2.91 | 2.78 | 2.02 | 1.01 | 1.01 | 0.53 | 0.72 |
| EPS Diluted
| 1.09 | 0.69 | 2.91 | 2.78 | 2.02 | 1.01 | 1.01 | 0.53 | 0.72 |
| EBITDA
| 285.222 | 204.66 | 411.933 | 382.565 | 281.513 | 149.024 | 111.936 | 69.251 | 83.28 |
| EBITDA Ratio
| 0.256 | 0.21 | 0.28 | 0.32 | 0.339 | 0.269 | 0.232 | 0.161 | 0.224 |